ANKRD66
gene geneOn this page
Summary
ANKRD66 (ankyrin repeat domain 66, HGNC:44669) is a protein-coding gene on chromosome 6p12.3, encoding Ankyrin repeat domain-containing protein 66 (B4E2M5).
At a glance
- Clinical variants (ClinVar): 52 total
- MANE Select transcript:
NM_001162435
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:44669 |
| Approved symbol | ANKRD66 |
| Name | ankyrin repeat domain 66 |
| Location | 6p12.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000230062 |
| Ensembl biotype | protein_coding |
| Entrez | 100287718 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000445060, ENST00000565422, ENST00000958136, ENST00000958137
RefSeq mRNA: 1 — MANE Select: NM_001162435
NM_001162435
CCDS: CCDS59024
Canonical transcript exons
ENST00000565422 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002228124 | 46751937 | 46752111 |
| ENSE00002314874 | 46753722 | 46753950 |
| ENSE00002581281 | 46746933 | 46746990 |
| ENSE00002587047 | 46758723 | 46759506 |
| ENSE00003565305 | 46749896 | 46749979 |
Expression profiles
Bgee: expression breadth broad, 37 present calls, max score 91.93.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2293 / max 78.7724, expressed in 53 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 68142 | 0.1896 | 48 |
| 68143 | 0.0271 | 10 |
| 204016 | 0.0126 | 5 |
Top tissues by expression
119 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 91.93 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 89.59 | gold quality |
| fallopian tube | UBERON:0003889 | 74.52 | gold quality |
| right lung | UBERON:0002167 | 64.90 | gold quality |
| endometrium | UBERON:0001295 | 60.55 | gold quality |
| left uterine tube | UBERON:0001303 | 52.21 | gold quality |
| lung | UBERON:0002048 | 50.73 | gold quality |
| prefrontal cortex | UBERON:0000451 | 48.12 | gold quality |
| caudate nucleus | UBERON:0001873 | 47.44 | gold quality |
| hypothalamus | UBERON:0001898 | 44.54 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 44.19 | gold quality |
| Ammon’s horn | UBERON:0001954 | 44.00 | gold quality |
| corpus callosum | UBERON:0002336 | 43.46 | gold quality |
| temporal lobe | UBERON:0001871 | 43.42 | gold quality |
| amygdala | UBERON:0001876 | 43.27 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.37 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 41.05 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 41.03 | gold quality |
| bone marrow cell | CL:0002092 | 40.77 | gold quality |
| frontal cortex | UBERON:0001870 | 40.17 | gold quality |
| endocervix | UBERON:0000458 | 40.15 | gold quality |
| cerebral cortex | UBERON:0000956 | 38.88 | gold quality |
| nucleus accumbens | UBERON:0001882 | 38.22 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 37.68 | silver quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| brain | UBERON:0000955 | 36.27 | gold quality |
| bone marrow | UBERON:0002371 | 35.22 | gold quality |
| monocyte | CL:0000576 | 35.19 | gold quality |
| apex of heart | UBERON:0002098 | 34.96 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.91 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
21 targeting ANKRD66, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-9902 | 99.89 | 69.15 | 2250 |
| HSA-MIR-3128 | 99.50 | 67.85 | 1258 |
| HSA-MIR-7109-5P | 99.18 | 66.13 | 1057 |
| HSA-MIR-328-5P | 99.08 | 64.65 | 1000 |
| HSA-MIR-6868-5P | 99.06 | 65.69 | 1284 |
| HSA-MIR-181A-2-3P | 98.91 | 67.60 | 1168 |
| HSA-MIR-6769B-5P | 98.73 | 64.91 | 1092 |
| HSA-MIR-6885-5P | 98.71 | 64.33 | 902 |
| HSA-MIR-6769A-5P | 97.99 | 64.16 | 851 |
| HSA-MIR-7113-5P | 97.88 | 67.33 | 1735 |
| HSA-MIR-4799-3P | 97.78 | 65.97 | 893 |
| HSA-MIR-4720-5P | 97.46 | 65.67 | 893 |
| HSA-MIR-5588-5P | 97.46 | 65.70 | 913 |
| HSA-MIR-6856-3P | 96.47 | 66.27 | 781 |
| HSA-MIR-1182 | 96.41 | 64.89 | 336 |
| HSA-MIR-9900 | 96.06 | 65.48 | 557 |
| HSA-MIR-1915-5P | 95.25 | 65.78 | 571 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ANKRD66 | ENSDARG00000090489 |
| mus_musculus | Ankrd66 | ENSMUSG00000096140 |
| rattus_norvegicus | Ankrd66 | ENSRNOG00000068669 |
Protein
Protein identifiers
Ankyrin repeat domain-containing protein 66 — B4E2M5 (reviewed: B4E2M5)
All UniProt accessions (2): B4E2M5, H3BTF0
UniProt curated annotations — full annotation on UniProt →
RefSeq proteins (1): NP_001155907* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002110 | Ankyrin_rpt | Repeat |
| IPR036770 | Ankyrin_rpt-contain_sf | Homologous_superfamily |
| IPR050776 | Ank_Repeat/CDKN_Inhibitor | Family |
Pfam: PF12796
UniProt features (6 total): repeat 3, chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-B4E2M5-F1 | 85.04 | 0.64 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 14 (showing top):
chr6p12, FOSTER_TOLERANT_MACROPHAGE_DN, METTL14_TARGET_GENES, SRSF9_TARGET_GENES, MIR1915_5P, MIR1182, GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS, DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS, DESCARTES_FETAL_CEREBRUM_ASTROCYTES, DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS, DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS, NOTCH3_TARGET_GENES, TRAVAGLINI_LUNG_CILIATED_CELL, TRAVAGLINI_LUNG_PROXIMAL_CILIATED_CELL
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
786 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ANKRD66 | ANKUB1 | A6NFN9 | 545 |
| ANKRD66 | HOATZ | Q6PI97 | 540 |
| ANKRD66 | LRRC71 | Q8N4P6 | 490 |
| ANKRD66 | FAM216B | Q8N7L0 | 469 |
| ANKRD66 | MAP3K19 | Q56UN5 | 446 |
| ANKRD66 | TMEM273 | Q5T292 | 423 |
| ANKRD66 | WDR31 | Q8NA23 | 418 |
| ANKRD66 | DYNLT5 | Q8N7M0 | 409 |
| ANKRD66 | ODAPH | Q17RF5 | 398 |
| ANKRD66 | CALHM2 | Q9HA72 | 384 |
| ANKRD66 | SERTAD4 | Q9NUC0 | 375 |
| ANKRD66 | TRAPPC8 | Q9Y2L5 | 368 |
| ANKRD66 | DAW1 | Q8N136 | 365 |
| ANKRD66 | TMC5 | Q6UXY8 | 362 |
| ANKRD66 | TMEM255A | Q5JRV8 | 361 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ANKRD66 | psi-mi:“MI:0915”(physical association) | 0.370 |
ESM2 similar proteins: A6NK59, A7MB89, B4E2M5, P0C6P7, P0C927, Q08DV6, Q29RM5, Q3SX45, Q3SZE4, Q3UMR0, Q495B1, Q4V890, Q5R5S1, Q5REW9, Q5RFS1, Q5U2S6, Q5ZM55, Q6GPE5, Q7T3P8, Q810B6, Q8C0T1, Q8C6Y6, Q8CEF1, Q8CEL2, Q8HXA6, Q8K0L0, Q8N9B4, Q8VHS6, Q8WXH4, Q8WXK1, Q91ZT8, Q96DX5, Q96JP0, Q96NW4, Q96Q27, Q9BSK4, Q9CQ31, Q9GKW8, Q9H0C1, Q9P2R3
Diamond homologs: A0A084B9Z8, B4E2M5, P42773, Q03017, Q4FE45, Q4JHE0, Q502M6, Q60772, Q61982, Q6RI86, Q8BLA8, Q9R172, Q9UM47, A0A0R4IQZ2, A5WVX9, B3DN87, B8A4F0, C8VCL4, E1BLT8, E7F587, E7FH11, E9PTT0, E9QCD3, F1Q7H8, F1QAM1, F1QHM7, F1QX91, O60069, O74384, O80685, P14585, P42836, P59267, P59268, Q04629, Q0WQK2, Q10L01, Q21920, Q2T9W8, Q2TGI5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
52 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
417 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:46746986:AGACA:A | donor_gain | 1.0000 |
| 6:46746987:GACA:G | donor_gain | 1.0000 |
| 6:46746987:GACAG:G | donor_gain | 1.0000 |
| 6:46746989:CA:C | donor_gain | 1.0000 |
| 6:46746991:G:GG | donor_gain | 1.0000 |
| 6:46749895:GGGCT:G | acceptor_gain | 1.0000 |
| 6:46749980:G:GG | donor_gain | 1.0000 |
| 6:46751932:CACA:C | acceptor_loss | 1.0000 |
| 6:46751934:CAGTT:C | acceptor_loss | 1.0000 |
| 6:46751935:A:AG | acceptor_gain | 1.0000 |
| 6:46751935:A:G | acceptor_loss | 1.0000 |
| 6:46751935:AGTT:A | acceptor_gain | 1.0000 |
| 6:46751936:G:GC | acceptor_gain | 1.0000 |
| 6:46751936:GT:G | acceptor_gain | 1.0000 |
| 6:46751936:GTT:G | acceptor_gain | 1.0000 |
| 6:46751936:GTTG:G | acceptor_gain | 1.0000 |
| 6:46751936:GTTGT:G | acceptor_gain | 1.0000 |
| 6:46752109:AAGG:A | donor_loss | 1.0000 |
| 6:46752112:GTGA:G | donor_loss | 1.0000 |
| 6:46753709:T:TA | acceptor_gain | 1.0000 |
| 6:46753951:G:GG | donor_gain | 1.0000 |
| 6:46746988:ACA:A | donor_gain | 0.9900 |
| 6:46746988:ACAGT:A | donor_loss | 0.9900 |
| 6:46746989:CAGT:C | donor_loss | 0.9900 |
| 6:46746990:AGTA:A | donor_loss | 0.9900 |
| 6:46746991:GTA:G | donor_loss | 0.9900 |
| 6:46749894:A:AG | acceptor_gain | 0.9900 |
| 6:46749894:AG:A | acceptor_gain | 0.9900 |
| 6:46749895:G:GG | acceptor_gain | 0.9900 |
| 6:46749895:GG:G | acceptor_gain | 0.9900 |
AlphaMissense
1650 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:46752082:G:C | R100P | 0.991 |
| 6:46753811:G:C | A140P | 0.989 |
| 6:46753908:C:A | A172E | 0.985 |
| 6:46752099:G:C | A106P | 0.984 |
| 6:46753805:T:C | F138L | 0.984 |
| 6:46753807:T:A | F138L | 0.984 |
| 6:46753807:T:G | F138L | 0.984 |
| 6:46753790:T:A | W133R | 0.983 |
| 6:46753790:T:C | W133R | 0.983 |
| 6:46753809:C:A | A139E | 0.983 |
| 6:46753907:G:C | A172P | 0.983 |
| 6:46752102:G:C | A107P | 0.981 |
| 6:46753812:C:A | A140E | 0.980 |
| 6:46752088:C:G | P102R | 0.979 |
| 6:46753877:G:C | D162H | 0.979 |
| 6:46753896:C:A | P168Q | 0.978 |
| 6:46753896:C:G | P168R | 0.977 |
| 6:46752100:C:A | A106D | 0.976 |
| 6:46751991:G:C | A70P | 0.975 |
| 6:46752088:C:A | P102Q | 0.975 |
| 6:46753792:G:C | W133C | 0.975 |
| 6:46753792:G:T | W133C | 0.975 |
| 6:46753879:C:A | D162E | 0.975 |
| 6:46753879:C:G | D162E | 0.975 |
| 6:46752096:T:A | W105R | 0.974 |
| 6:46752096:T:C | W105R | 0.974 |
| 6:46753779:C:T | T129I | 0.973 |
| 6:46753800:C:A | A136D | 0.972 |
| 6:46752103:C:A | A107E | 0.971 |
| 6:46752063:G:C | D94H | 0.970 |
dbSNP variants (sampled 300 via entrez): RS1000069057 (6:46759281 G>A), RS1000202916 (6:46746882 G>A,T), RS1000457613 (6:46754141 G>A), RS1001067536 (6:46748752 T>G), RS1001216448 (6:46751324 G>A), RS1001278496 (6:46751471 C>A,T), RS1001288036 (6:46746056 T>C), RS1001319820 (6:46745529 C>T), RS1001424845 (6:46746102 T>C,G), RS1001451783 (6:46759912 G>A), RS1001584183 (6:46751494 T>A,G), RS1001690987 (6:46757558 C>G,T), RS1001855212 (6:46756224 C>A,T), RS1002074491 (6:46756418 AG>A), RS1002405010 (6:46746920 G>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation | 2 |
| Smoke | increases expression, increases abundance | 2 |
| bisphenol S | affects cotreatment, increases methylation | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.